Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. - Wikidata - wikimedia - TriplyDB

Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.

Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.

http://www.wikidata.org/entity/Q44739223

about

Nitric oxide and peroxynitrite in health and disease Vascular actions of 20-HETE Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population 20-HETE and blood pressure regulation: clinical implications Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure CYP1B1 and endothelial nitric oxide synthase combine to sustain proangiogenic functions of endothelial cells under hyperoxic stress 20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury.Vascular characterization of mice with endothelial expression of cytochrome P450 4F2.20-HETE-induced nitric oxide production in pulmonary artery endothelial cells is mediated by NADPH oxidase, H2O2, and PI3-kinase/Akt.A synthetic analogue of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension via increased 20-HETE levels associated with decreased iNOS protein expression and vasodilator prostanoid production in rats Renal function and vasomotor activity in mice lacking the Cyp4a14 gene.The role of 20-HETE in androgen-mediated hypertension.Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.2,3',4,5'-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1 20-Hydroxyeicosatetraenoic acid involved in endothelial activation and thrombosis.Dietary Omega-3 Polyunsaturated Fatty Acids Prevent Vascular Dysfunction and Attenuate Cytochrome P4501A1 Expression by 2,3,7,8-Tetrachlorodibenzo-P-Dioxin.Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase.Chronic activation of AMP-activated protein kinase prevents 20-hydroxyeicosatetraenoic acid-induced endothelial dysfunction.20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease.Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids.20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter Binding Treatment with the cytochrome P450 ω-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation, oxidative stress and improves vasomotor function in spontaneously hypertensive rats.Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.A 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated rats.20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE.Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL.20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury.Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.Modulation of cardiac cytochrome P450 in patients with heart failure.

P2860

Q24645400-D888E608-FB0F-48F9-A48A-13F6EDC2E558 Q28259468-3B889F95-89B6-4FBB-B0BE-E99F5FD32FDE Q28272355-D70D33E0-E794-4F72-96FC-131BF824DD87 Q28288942-18460D7C-3262-462F-9DA3-3AB8ED0C7681 Q28384214-9821EFA5-E9FB-42C1-83DD-AF15AE554B61 Q28509077-1D0EE0B3-6F17-46F3-B13B-90ABFB9B16AD Q33574917-0EDE5FE5-D651-442D-AF57-C568F0520ECC Q33700011-CF7A10EC-9DF4-40D3-AFA7-6A4F5DC09F37 Q33775129-22DE357A-B212-41C3-BF4A-14E229299C90 Q33784118-34217076-4C83-4456-A328-354A8D85B4A4 Q33900988-FA3212DA-815B-46AC-B8DD-D735B64B3CA4 Q34143379-B1748432-E6DC-4AD3-A4B7-42AB27BDEB7D Q34196923-18C8B462-4EB9-45B6-AD5C-52D783810978 Q34342711-C46A06DE-86E0-4F2E-84F8-CEB4E7429299 Q34369965-9BBF193A-621F-4B94-88A8-B9A5923E378D Q34378817-FA068541-614B-4546-9771-CBF16A3D7A73 Q34426173-C02EE6F4-3370-4AED-91B3-FCE87B66E9E2 Q34469211-630D5603-2FBC-4F07-8D1A-F6A8480582A3 Q34536466-3FF20518-B214-4866-80F5-B5D215C3D427 Q34780122-EF220166-7799-4743-8FCF-C9DC69D38BC6 Q34918014-F3A4F7A6-BDD2-4415-965E-FA244D6B2EB3 Q34924935-F7F40DF6-A14A-4DAC-9EEE-0917699000C9 Q35817958-067BE8A2-DAD1-4ED7-8342-70CAD4757396 Q35981986-9528AEA1-09FC-4155-A513-1D46F30D602E Q36074375-53C5B930-5626-4F91-B6DA-F217A1E213FE Q36432334-51429CF9-3AFB-4799-9013-0FB717FB94FA Q36618716-9298FC87-112A-4FD9-BCF0-D8B4C1B22700 Q36757000-168B2FB2-1E3D-4800-9B50-3304D67F1648 Q37038745-7C7A3A1E-C8B4-41EF-A52A-3B2FFD3A7BC5 Q37041257-60BF4CA6-EDDB-4AA0-ACC5-44598F7B2585 Q37138971-A52E4CBC-BBBD-4AE4-BEB2-A1831555F22A Q37142503-C20B62A7-8DF3-46E0-A643-E3EA48D6AE9A Q37230725-2F7481BE-B217-44FD-82D0-F875F407F051 Q37340856-B7493863-72F8-43BC-837B-F65FC5A50A3C Q37417272-B1C2D3F0-ACDD-4029-B809-799FFAE3BA7C Q37619813-5E305E7E-08BE-4BB2-BDED-456B694BFDE8 Q37798679-0204BA16-AA23-4FB8-B0BC-5EA647B4AB93 Q38083851-30221746-A7E6-42A0-96F1-71913BED329B Q38100223-4D4F7CBE-6266-447C-B0F8-246138886AB9 Q38175461-51809758-B8D7-42AC-B4EF-016B3C0229A5

P2860

Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.

http://www.wikidata.org/entity/Q44739223

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.

@en

Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.

@nl

type

label

Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.

@en

Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.

@nl

prefLabel

Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.

@en

Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.

@nl

P1433

Q44739223-0CFE3943-19F6-4234-954F-1320B7DF38B6

P1476

Q44739223-46F9052D-ACF0-41DB-8427-C2C6EE55FA3D

P2093

Q44739223-1EB07B1B-E532-4293-8F24-962471FACFE9

Q44739223-67F833F4-DFA3-4656-9988-50AEB0A9AC9C

Q44739223-861C6372-4BC5-4AB1-9C46-2F54A3907576

Q44739223-AC0974B6-2548-4EF9-B0E5-9F5651ED1166

Q44739223-B1AD0F35-2BA3-436C-9F9B-AF3FD42017F5

Q44739223-BC27642A-E298-449F-8F14-8ECF973D5186

Q44739223-C85E2D31-4295-4544-AE69-9EAC4DE3DCED

Q44739223-CDB2B160-962B-422F-B2CB-5AC39213B9DF

Q44739223-F95E3F04-8522-4C98-9D76-B03FA6B2DC22

Q44739223-FD7BCA41-3355-4E46-B40F-939AEA48FA69

P304

Q44739223-6B4B1DCD-3215-417E-BF1A-5E674032B941

P31

Q44739223-4E04B8ED-A758-456C-99B0-0A150EA2C1F2

P356

Q44739223-A3298851-F8BD-488D-9C6E-556C0A86E0F3

P433

Q44739223-18471DBD-43DF-4FE4-A4BC-E8A369EE1BE5

P478

Q44739223-66AB0155-460C-4C6E-861F-A74ABD3AB57F

P50

Q44739223-2B483552-5400-451D-AD29-DB2CB94305A5

Q44739223-48DDA656-A42F-4FF2-8B50-99ABCB21B00F

P577

Q44739223-861EF4F8-ECA9-423A-AFE7-4D26C8AD0BD1

P5875

Q44739223-BA44837A-52EA-44DB-8A0F-184BD45396B6

P698

Q44739223-14ECE880-027E-4C24-B1DA-FF8C78FDEFDD

P921

Q44739223-A8A6F683-B3DC-46FB-9EBA-331D500D190E

Q44739223-C00356F6-6F68-428E-A5F5-02D82A2C05B7

P356

01.RES.0000217283.98806.A6

P1433

Circulation Research

P1476

Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.

@en

P2093

Alberto Nasjletti

http://www.w3.org/2001/XMLSchema#string

Frank Zhang

http://www.w3.org/2001/XMLSchema#string

Harpreet Singh

http://www.w3.org/2001/XMLSchema#string

Huan Deng

http://www.w3.org/2001/XMLSchema#string

Ji-Shi Wang

http://www.w3.org/2001/XMLSchema#string

Michael S Wolin

http://www.w3.org/2001/XMLSchema#string

Michal Laniado-Schwartzman

http://www.w3.org/2001/XMLSchema#string

Nader G Abraham

http://www.w3.org/2001/XMLSchema#string

Rowena Kemp

http://www.w3.org/2001/XMLSchema#string

Thomas H Hintze

http://www.w3.org/2001/XMLSchema#string

P304

962-969

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.RES.0000217283.98806.A6

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

Michal Laniado-Schwartzman

Alberto Nasjletti

P577

2006-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7234377

http://www.w3.org/2001/XMLSchema#string

P698

16543501

http://www.w3.org/2001/XMLSchema#string

P921